Cabinet to assess 20 drugs in 2016 under new rules

Ministers charged with making life or death calls

Susan Mitchell

Deputy Editor and Health Editor @susmitchellsbp
28th August, 2016
HSE director general Tony OBrien Pic:

Twenty expensive new medicines are expected to go to cabinet for approval this year, the Department of Health has said.

Under a radically changed approval process, the government now has to approve expensive medicines before the Health Service Executive (HSE) will pay for them.

New drugs to treat cancer, high cholesterol and cystic fibrosis are at various stages of the assessment process at present. The cumulative cost of these medicines is about €300 million per...

Subscribe from just €1 for the first month!

Exclusive offers:

All Digital Access + eReader



Unlimited Access for 1 Month

Get basic

*New subscribers only

You can cancel any time.



€149 For the 1st Year

Unlimited Access for 1 Year

You can cancel any time.




90 Day Pass

You can cancel any time.

2 Yearly



Unlimited Access for 2 Years

You can cancel any time.

Team Pass

Get a Business Account for you and your team

Share this post

Related Stories

Analysis: Variants and vaccines make projecting path of virus more complex

Health Rachel Lavin 2 days ago

HSE’s latest private hospitals Covid deal estimated to cost €47 million a month

Health Daniel Murray 6 days ago

Key public health posts remain vacant

Health Daniel Murray 6 days ago

Breakdown of HSE’s €1.6 billion war chest to fight Covid-19

Health Daniel Murray 6 days ago